Even medical device companies now rely on digital health to maintain their competitive edge.
On March 6, 2017, Thermo Fisher Scientific Inc. (NYSE: TMO), maker of analytical instruments, equipment, reagents and consumables, software and services for research, moved into the eHealth space with its purchase of privately held Core Informatics. Financial terms were not disclosed.
Thomas Loewald, senior vice president and chief commercial officer, Thermo Fisher Scientific, stated in a press release, “The scientific community is rapidly adopting cloud-based laboratory and scientific data management capabilities. Integrating the leading technologies of Core Informatics is part of our strategy to set the standard for digital science solutions, from life sciences discovery to applied markets and manufacturing.”
Based in Connecticut, Core Informatics capabilities include laboratory information management systems, electronic laboratory notebook technologies and scientific data management solutions. It partners with customers in biopharma and genomics to deliver lab informatics solutions to derive more value and insight from their scientific data.
Core’s offerings will significantly enhance Thermo Fisher’s existing informatics solutions and complement its cloud platform, which supports the company’s genetic analysis, qPCR and proteomics systems.
Prior to this deal, Thermo Fisher’s most recent deal was of FEI Company (NASDAQ: FEIC) in May 2016 for $4.2 billion. FEI, a medical device company, supplies scientific instruments and related services for nanoscale applications and solutions.